Open AccessLong-term effect of antifungal therapy for the treatment of severe resistant asthma: an active comparator clinical trial
Author(s) -
Majid Mirsadraee,
Sanaz Dehghan,
Shadi Ghaffari,
Niloofar Mirsadraee
Publication year - 2019
Publication title -
current medical mycology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.369
H-Index - 6
eISSN - 2423-3439
pISSN - 2423-3420
DOI - 10.18502/cmm.5.4.1986
Subject(s) - itraconazole , medicine , asthma , adverse effect , clinical trial , prednisolone , clinical endpoint , randomized controlled trial , anesthesia , antifungal , dermatology
Itraconazole therapy has been reported to control asthma in severe therapy-resistant asthma with fungal sensitization. The aim of this study was to investigate the impact of anti-fungal therapy on the treatment of severe asthma, irrespective of sensitization.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom